Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.86B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
Mercado Libre
MELI
|
+$1.59B |
| 4 |
TSMC
TSM
|
+$1.34B |
| 5 |
Coupang
CPNG
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$2.61B |
| 2 |
EPAM Systems
EPAM
|
+$1.48B |
| 3 |
Twilio
TWLO
|
+$1.35B |
| 4 |
Apple
AAPL
|
+$1.24B |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.54% |
| 2 | Healthcare | 9.8% |
| 3 | Financials | 9.16% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
National Beverage
FIZZ
$2.94B
| $6.51M | ﹤0.01% |
149,637
+2,756
| +2% | +$120K |
|
|
DOG
3352
ProShares Short Dow30
DOG
$87.5M
| $6.51M | ﹤0.01% |
199,058
-789,203
| -80% | -$26M |
|
3353
Monro
MNRO
$352M
| $6.5M | ﹤0.01% |
146,588
+20,497
| +16% | +$1,000K |
|
3354
ALX Oncology
ALXO
$274M
| $6.5M | ﹤0.01% |
384,518
+129,818
| +51% | +$2.22M |
|
3355
First Trust Global Wind Energy ETF
FAN
$284M
| $6.49M | ﹤0.01% |
328,377
-65,537
| -17% | -$1.24M |
|
|
PPT
3356
Franklin Premier Income Trust
PPT
$331M
| $6.47M | ﹤0.01% |
1,620,435
+41,242
| +3% | +$167K |
|
|
KYNB
3357
Kyntra Bio
KYNB
$28.8M
| $6.46M | ﹤0.01% |
21,517
+10,339
| +92% | +$3.6M |
|
3358
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$249M
| $6.46M | ﹤0.01% |
276,657
+41,212
| +18% | +$994K |
|
3359
Marcus & Millichap
MMI
$1.19B
| $6.46M | ﹤0.01% |
122,620
-45,787
| -27% | -$2.19M |
|
3360
Central Garden & Pet Co Class A
CENTA
$2.37B
| $6.46M | ﹤0.01% |
197,840
-61,674
| -24% | -$2.12M |
|
3361
Perdoceo Education
PRDO
$1.97B
| $6.46M | ﹤0.01% |
562,194
+95,529
| +20% | +$1.06M |
|
3362
Post Holdings
POST
$3.66B
| $6.45M | ﹤0.01% |
93,143
-169,341
| -65% | -$11.8M |
|
|
YMAB
3363
DELISTED
Y-mAbs Therapeutics
YMAB
| $6.43M | ﹤0.01% |
541,561
+251,177
| +86% | +$2.58M |
|
|
CCRN
3364
DELISTED
Cross Country Healthcare
CCRN
| $6.43M | ﹤0.01% |
296,880
+97,291
| +49% | +$2.11M |
|
3365
ePlus
PLUS
$2.31B
| $6.43M | ﹤0.01% |
114,673
-20,446
| -15% | -$1.02M |
|
3366
Nuveen ESG Mid-Cap Growth ETF
NUMG
$375M
| $6.43M | ﹤0.01% |
146,658
+71,584
| +95% | +$3.09M |
|
3367
Zai Lab
ZLAB
$2.9B
| $6.42M | ﹤0.01% |
146,031
-82,026
| -36% | -$3.97M |
|
3368
Sibanye-Stillwater
SBSW
$7.6B
| $6.42M | ﹤0.01% |
395,625
-187,835
| -32% | -$3.04M |
|
|
DCPH
3369
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.42M | ﹤0.01% |
692,624
+459,504
| +197% | +$3.91M |
|
3370
Northern Oil and Gas
NOG
$2.61B
| $6.42M | ﹤0.01% |
227,671
-8,058
| -3% | -$198K |
|
3371
Avantis US Equity ETF
AVUS
$14.4B
| $6.41M | ﹤0.01% |
83,169
+39,877
| +92% | +$3.04M |
|
3372
Theravance Biopharma
TBPH
$880M
| $6.41M | ﹤0.01% |
670,004
-809,025
| -55% | -$7.93M |
|
3373
Banc of California
BANC
$3.11B
| $6.4M | ﹤0.01% |
330,783
+98,445
| +42% | +$1.96M |
|
3374
Interparfums
IPAR
$3.67B
| $6.4M | ﹤0.01% |
72,730
-28,896
| -28% | -$2.67M |
|
|
MYOV
3375
DELISTED
Myovant Sciences Ltd.
MYOV
| $6.4M | ﹤0.01% |
480,676
+134,274
| +39% | +$1.8M |
|
Similar funds
Morgan Stanley's Q1 2022 Portfolio in Review
As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
- Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
- Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
- Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
- Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
- Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
- Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.